Clinical Trial Update: Resveratrol for Alzheimer's Disease [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial evaluating resveratrol for Alzheimer's disease and notes that the trial results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Resveratrol (resveratrol)

Snippet

Sponsor: Alzheimer's Disease Cooperative Study (ADCS) | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2016-06-14